The increasing fraction of low-solubility compounds in drug discovery has necessitated routine use of enabling technologies to improve oral drug absorption and bioavailability. However, choice of the best enabling technology can be challenging. Lonza Pharma & Biotech employs a proven design and development roadmap based on extensive experience in bioavailability enhancement with a wide range of compounds. To learn more, please see our technical brief.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center